tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OTLK Stock Latest News

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/24/25
Market NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—12/24/25
1d ago
EB
VTI
Outlook Therapeutics: Strengthened Case for ONS-5010 Drives Attractive Risk/Reward and Increased $10 Price Target
PremiumRatings
Outlook Therapeutics: Strengthened Case for ONS-5010 Drives Attractive Risk/Reward and Increased $10 Price Target
1d ago
OTLK
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/23/25
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/23/25
2d ago
EB
VTI
Vanguard Total Stock Market ETF (VTI) Daily Update—12/22/25
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Update—12/22/25
3d ago
VTI
AAPL
Outlook Therapeutics reports FY25 EPS ($1.79) vs ($4.06) last year
PremiumThe Fly
Outlook Therapeutics reports FY25 EPS ($1.79) vs ($4.06) last year
6d ago
OTLK
Outlook Therapeutics (OTLK) Q4 Earnings Cheat Sheet
PremiumPre-EarningsOutlook Therapeutics (OTLK) Q4 Earnings Cheat Sheet
9d ago
OTLK
Outlook Therapeutics’ FDA Review for ONS-5010 Resubmission
Premium
Company Announcements
Outlook Therapeutics’ FDA Review for ONS-5010 Resubmission
1M ago
8K
OTLK
Outlook Therapeutics announces acceptance of BLA for ONS-5010
Premium
The Fly
Outlook Therapeutics announces acceptance of BLA for ONS-5010
1M ago
OTLK
Outlook Therapeutics Resubmits Biologics License Application
PremiumCompany Announcements
Outlook Therapeutics Resubmits Biologics License Application
2M ago
8K
OTLK
Outlook Therapeutics resubmits BLA for ONS-5010
PremiumThe Fly
Outlook Therapeutics resubmits BLA for ONS-5010
2M ago
OTLK
Outlook Therapeutics: Hold Rating Amid Uncertainties in BLA Resubmission and Market Challenges
PremiumRatings
Outlook Therapeutics: Hold Rating Amid Uncertainties in BLA Resubmission and Market Challenges
3M ago
OTLK
Outlook Therapeutics Completes FDA Meeting on ONS-5010
PremiumCompany Announcements
Outlook Therapeutics Completes FDA Meeting on ONS-5010
3M ago
8K
OTLK
Outlook Therapeutics says plans to resubmit BLA before end of CY25
PremiumThe FlyOutlook Therapeutics says plans to resubmit BLA before end of CY25
3M ago
OTLK
Outlook Therapeutics says had ‘productive’ discussion with FDA
Premium
The Fly
Outlook Therapeutics says had ‘productive’ discussion with FDA
3M ago
OTLK
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
BNC
MBX
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
RDW
KYIV
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
RDW
BULL
Outlook Therapeutics CCO Jeff Evanson Steps Down
PremiumCompany Announcements
Outlook Therapeutics CCO Jeff Evanson Steps Down
4M ago
8K
OTLK
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
SU
LIT
FDA Issues Complete Response Letter to Outlook Therapeutics
PremiumCompany AnnouncementsFDA Issues Complete Response Letter to Outlook Therapeutics
4M ago
8K
OTLK
Outlook Therapeutics submits Type A meeting request to FDA
Premium
The Fly
Outlook Therapeutics submits Type A meeting request to FDA
4M ago
OTLK
Marvell downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
Premium
The Fly
Marvell downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
4M ago
AHL
SWX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >